Jun-Chang Jeong
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jun-Chang Jeong has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
- Sun Oh Kim
Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University Health System, Seoul, Korea
5 shared publications - Hong-Ju Kim
Division of Cardiology, Department of Internal Medicine, Yeungnam University Medical Center, Yeungnam University College of Medicine, Daegu, Republic of Korea
3 shared publications - Jong-Il Park
Division of Cardiology, Yeungnam University Medical Center, Daegu, Korea
3 shared publications - Ung Kim
Division of Cardiology, Department of Internal Medicine, Yeungnam University Medical Center, Daegu, Korea
3 shared publications - Byeng-Ju Son
Division of Cardiology, Department of Internal Medicine Dongkang Medical Center Ulsan Republic of Korea
2 shared publications - Young-Guk Ko
Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, Korea
2 shared publications
Latest Publications
- Open Access
- 6 November 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (45)
Human carotid plaque risk imaging using multiparametric photoacoustic and ultrasound fusion (hCAPRI)
Assessing the risk of carotid plaque rupture remains limited because current imaging methods cannot provide both plaque composition and structural information in real time. Here, we present human carotid plaque risk imaging (hCAPRI), a multiparametric photoacoustic and ultrasound (PA/US) fusion method for real-time carotid plaque assessment. hCAPRI combines PA imaging for detecting intraplaque hemorrhage (IPH) with US imaging for evaluating the plaque structure. PA imaging measured IPH size and methemoglobin content, while US imaging assessed stenosis severity, calcification, and plaque thickness. Combining these PA/US parameters, we compute an hCAPRI score. In 171 carotid arteries (CAs) from 120 patients, hCAPRI revealed the relationships among the PA/US parameters. In 36 CAs validated with magnetic resonance imaging (MRI), hCAPRI showed high agreement with MRI. The hCAPRI score achieved 89% sensitivity and 84% specificity for high-risk plaque classification. hCAPRI offers a low-cost, real-time, and contrast-free approach for carotid plaque risk imaging.
- 6 November 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (45)
Open AccessHuman carotid plaque risk imaging using multiparametric photoacoustic and ultrasound fusion (hCAPRI)
Assessing the risk of carotid plaque rupture remains limited because current imaging methods cannot provide both plaque composition and structural information in real time. Here, we present human carotid plaque risk imaging (hCAPRI), a multiparametric photoacoustic and ultrasound (PA/US) fusion method for real-time carotid plaque assessment. hCAPRI combines PA imaging for detecting intraplaque hemorrhage (IPH) with US imaging for evaluating the plaque structure. PA imaging measured IPH size and methemoglobin content, while US imaging assessed stenosis severity, calcification, and plaque thickness. Combining these PA/US parameters, we compute an hCAPRI score. In 171 carotid arteries (CAs) from 120 patients, hCAPRI revealed the relationships among the PA/US parameters. In 36 CAs validated with magnetic resonance imaging (MRI), hCAPRI showed high agreement with MRI. The hCAPRI score achieved 89% sensitivity and 84% specificity for high-risk plaque classification. hCAPRI offers a low-cost, real-time, and contrast-free approach for carotid plaque risk imaging.
- 24 March 2026
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 107 (6) , 2032-2035
Systemic Thrombolytic Resistance in Antithrombin III Deficiency Rescued by Catheter‐Directed Thrombolysis: A Case Report
Background: Hereditary antithrombin III (AT III) deficiency is a rare thrombophilic disorder that may cause resistance to systemic thrombolytic therapy. We report a case of massive iliofemoral deep‐vein thrombosis (DVT) with high‐risk pulmonary thromboembolism (PTE) refractory to systemic thrombolysis, successfully treated with catheter‐directed thrombolysis (CDT). Case Summary: A previously healthy 33‐year‐old man presented with dyspnoea and left‐leg swelling. Imaging revealed bilateral pulmonary‐artery thrombi with acute right‐ventricular failure and extensive iliofemoral DVT. Despite systemic alteplase infusion, thrombus resolution was incomplete, and hereditary AT III deficiency (53% activity) was diagnosed. CDT via the right femoral vein was performed using alteplase (0.02 mg/kg/h for 48 h), achieving near‐complete thrombus resolution and restoration of venous flow without bleeding complications. Discussion: This case highlights systemic thrombolysis failure associated with AT III deficiency and demonstrates that CDT can serve as an effective, low‐bleeding‐risk rescue therapy for extensive DVT when systemic treatment is inadequate. These findings underscore the importance of early recognition of AT III deficiency and consideration of catheter‐based intervention in similar high‐risk settings.
- 24 March 2026
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 107 (6) , 2032-2035
Systemic Thrombolytic Resistance in Antithrombin III Deficiency Rescued by Catheter‐Directed Thrombolysis: A Case Report
Background: Hereditary antithrombin III (AT III) deficiency is a rare thrombophilic disorder that may cause resistance to systemic thrombolytic therapy. We report a case of massive iliofemoral deep‐vein thrombosis (DVT) with high‐risk pulmonary thromboembolism (PTE) refractory to systemic thrombolysis, successfully treated with catheter‐directed thrombolysis (CDT). Case Summary: A previously healthy 33‐year‐old man presented with dyspnoea and left‐leg swelling. Imaging revealed bilateral pulmonary‐artery thrombi with acute right‐ventricular failure and extensive iliofemoral DVT. Despite systemic alteplase infusion, thrombus resolution was incomplete, and hereditary AT III deficiency (53% activity) was diagnosed. CDT via the right femoral vein was performed using alteplase (0.02 mg/kg/h for 48 h), achieving near‐complete thrombus resolution and restoration of venous flow without bleeding complications. Discussion: This case highlights systemic thrombolysis failure associated with AT III deficiency and demonstrates that CDT can serve as an effective, low‐bleeding‐risk rescue therapy for extensive DVT when systemic treatment is inadequate. These findings underscore the importance of early recognition of AT III deficiency and consideration of catheter‐based intervention in similar high‐risk settings.
- Open Access
- 1 January 2026
- Published by XMLink in Korean Circulation Journal
- Vol. 56 (7) , 649-654
Rescue Chimney Stenting via Direct Carotid Access for Inadvertent Left Common Carotid Artery Coverage During Zone 2 Thoracic Endovascular Aortic Repair
Kemalasari AD, et al. Korean Circ J. 2026 ;56:e86. https://doi.org/10.4070/kcj.2025.0504
- 1 January 2026
- Published by XMLink in Korean Circulation Journal
- Vol. 56 (7) , 649-654
Open AccessRescue Chimney Stenting via Direct Carotid Access for Inadvertent Left Common Carotid Artery Coverage During Zone 2 Thoracic Endovascular Aortic Repair
Kemalasari AD, et al. Korean Circ J. 2026 ;56:e86. https://doi.org/10.4070/kcj.2025.0504
- Open Access
- 18 July 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (29) , e43400
Malignant hypertension-induced multiorgan failure and acute limb ischemia in a young adult: A case report
Rationale: Malignant hypertension (MHT) is characterized by a systolic blood pressure (BP) of ≥ 180 mm Hg and/or a diastolic BP of ≥120 mm Hg, accompanied by acute target organ damage. While it often results in multiorgan failure, the development of a left ventricular (LV) thrombus and subsequent acute limb ischemia (ALI) is rare. Patient concerns: A 26-year-old Korean male with untreated hypertension presented with MHT and discoloration of the right lower extremity. The affected limb exhibited classic signs of ALI. Diagnoses: Computed tomography angiography revealed a right renal infarction and total occlusion of the right distal superficial femoral artery. Echocardiography demonstrated a reduced ejection fraction of 32% and a LV thrombus. Hybrid 18-fluoro-deoxyglucose (FDG) positron emission tomography/magnetic resonance imaging revealed no abnormal FDG uptake or late gadolinium enhancement, ruling out myocardial inflammation, fibrosis, or scarring and confirming MHT as the cause of LV dysfunction and thrombus. Interventions: The patient underwent percutaneous transluminal angioplasty and Fogarty embolectomy, successfully restoring blood flow. Fasciotomy was performed to manage reperfusion injury. Outcomes: The symptoms and blood flow in the right lower extremity were restored. Follow-up echocardiography showed an improved ejection fraction of 50% and resolution of the LV thrombus. The patient continued to improve, was discharged, and is currently undergoing rehabilitation therapy. Lessons: Hypertension should be proactively managed to prevent life-threatening complications. Timely intervention, particularly in cases of severe complications, is essential for optimizing patient outcomes.
- 18 July 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (29) , e43400
Open AccessMalignant hypertension-induced multiorgan failure and acute limb ischemia in a young adult: A case report
Rationale: Malignant hypertension (MHT) is characterized by a systolic blood pressure (BP) of ≥ 180 mm Hg and/or a diastolic BP of ≥120 mm Hg, accompanied by acute target organ damage. While it often results in multiorgan failure, the development of a left ventricular (LV) thrombus and subsequent acute limb ischemia (ALI) is rare. Patient concerns: A 26-year-old Korean male with untreated hypertension presented with MHT and discoloration of the right lower extremity. The affected limb exhibited classic signs of ALI. Diagnoses: Computed tomography angiography revealed a right renal infarction and total occlusion of the right distal superficial femoral artery. Echocardiography demonstrated a reduced ejection fraction of 32% and a LV thrombus. Hybrid 18-fluoro-deoxyglucose (FDG) positron emission tomography/magnetic resonance imaging revealed no abnormal FDG uptake or late gadolinium enhancement, ruling out myocardial inflammation, fibrosis, or scarring and confirming MHT as the cause of LV dysfunction and thrombus. Interventions: The patient underwent percutaneous transluminal angioplasty and Fogarty embolectomy, successfully restoring blood flow. Fasciotomy was performed to manage reperfusion injury. Outcomes: The symptoms and blood flow in the right lower extremity were restored. Follow-up echocardiography showed an improved ejection fraction of 50% and resolution of the LV thrombus. The patient continued to improve, was discharged, and is currently undergoing rehabilitation therapy. Lessons: Hypertension should be proactively managed to prevent life-threatening complications. Timely intervention, particularly in cases of severe complications, is essential for optimizing patient outcomes.
- Open Access
- 1 January 2025
- Published by XMLink in Korean Circulation Journal
- Vol. 55 (11) , 1049-1053
Customized Fenestrated Thoracic Endovascular Aneurysm Repair in an Elderly Patient With Complex Visceral Anatomy
Jeong JC, et al. Korean Circ J. 2025 Oct;55:e133. https://doi.org/10.4070/kcj.2025.0233
- 1 January 2025
- Published by XMLink in Korean Circulation Journal
- Vol. 55 (11) , 1049-1053
Open AccessCustomized Fenestrated Thoracic Endovascular Aneurysm Repair in an Elderly Patient With Complex Visceral Anatomy
Jeong JC, et al. Korean Circ J. 2025 Oct;55:e133. https://doi.org/10.4070/kcj.2025.0233
- 7 November 2023
- Published by Wolters Kluwer Health in Circulation
- Vol. 148 (Suppl_1)
Abstract 16753: Effectiveness of Guideline-Endorsed Low-Density Lipoprotein Cholesterol Reduction Rates in Patients With Prior Percutaneous Coronary Intervention
- 7 November 2023
- Published by Wolters Kluwer Health in Circulation
- Vol. 148 (Suppl_1)
Abstract 16753: Effectiveness of Guideline-Endorsed Low-Density Lipoprotein Cholesterol Reduction Rates in Patients With Prior Percutaneous Coronary Intervention